HOD HASHARON, Israel, Sept. 9, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has entered into an Exclusive License Agreement with U.S.-based Copernicus Therapeutics, I

FRISCO, Texas, Sept. 9, 2019 /PRNewswire/ -- Addus HomeCare Corporation (Nasdaq: ADUS) ("Addus" or the "Company"), a provider of comprehensive home care services, today announced the closing of an underwritten public offering of 2,300,000 shares of its common stock ("Common Stock"), including 300,000 shares of Common Stock sold pursuant to the exercise in ful

CUPERTINO, Calif., Sept. 9, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that further development of a long-acting injectable HIV investigational product utilizing

NEW YORK and SHANGHAI, Sept. 9, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a bioph

WILLMINGTON, Del., Sept. 9, 2019 /PRNewswire/ -- NeuroRX, a phase 3 biopharma company focused on development of NRX-101, an FDA-designated Breakthrough Therapy for Severe Bipolar Depression with Acute Suicidal Ideation, will present a corporate overview at today's H.C. Wainwright 21st Annual Global Investment Conference in New York. In addition to the presentation by Dr.

STOCKHOLM, Sept. 9, 2019 /PRNewswire/ -- A feasibility study performed as a Master Thesis at Uppsala University and supervised by Diamyd Medical, supports the use of ultrasound guided intralymphatic injections for clinical routine use. This pilot study is based on interviews with and answers to questionnaires from selected radiologists and

SANTA CLARA, Calif., Sept. 9, 2019 /PRNewswire/ -- With the future of the Affordable Care Act (ACA) soon to be decided by the case of Texas v. United States, eHealth, Inc. (NASDAQ: EHTH) (

SAN FRANCISCO, Sept. 9, 2019 /PRNewswire/ -- Healthline Media's popular health website Medical News Today (MNT) jumped to #3 in the online health information category

DURHAM, N.C., Sept. 9, 2019 /PRNewswire/ -- MindPath Care Centers, the state's largest outpatient mental and behavioral healthcare provider, is pleased to announce that Diego Garza, M.D., Vice President of Strategy and Innovation at MindPath Care Centers, has been invited to be a speaker at the North Carolina Medical Society (NCMS)'s second

SAN DIEGO, Sept. 9, 2019 /PRNewswire/ -- Epic Sciences, Inc. today announced the appointment of Joel Smith as its general counsel and executive vice president of corporate development. Mr. Smith joins the company's impressive roster of industry veterans."Joel's appointment comes at a pivotal time for Epic Sciences as we bui